Management of Needlestick Injury with Confirmed Hepatitis C Source

Immediate Actions

The Centers for Disease Control and Prevention recommends baseline testing, including anti-HCV antibody and alanine aminotransferase (ALT) tests, immediately after exposure to enable early detection and treatment if infection occurs 1, 2, 4
Documenting the exposed person's baseline HCV status and the exposure details, such as date, time, type of device involved, severity of injury, and source patient's HCV RNA status if available, is crucial for follow-up and treatment 4, 5, 6

The standard follow-up schedule for HCV exposure includes HCV RNA testing at 4-6 weeks post-exposure if earlier diagnosis is desired, and anti-HCV antibody and ALT testing at 4-6 months post-exposure 1, 2, 5, 6, 4, 3
Confirming any positive anti-HCV results with supplemental assays, such as RIBA, before communicating results to the patient is essential, particularly if signal-to-cutoff values are low 5, 6, 4

The average risk of HCV transmission after needlestick from a confirmed positive source is 1.8% (range 0-7%), which is substantially lower than hepatitis B but higher than HIV 4, 3

The Centers for Disease Control and Prevention advises that no special precautions are needed to prevent secondary transmission during the follow-up period, and no modification of patient care responsibilities is necessary 1, 2, 7, 4
Exposed healthcare workers should seek immediate medical evaluation for any acute illness during follow-up, particularly symptoms of acute hepatitis, such as fatigue, jaundice, nausea, and right upper quadrant pain 1, 2, 7, 4

The Centers for Disease Control and Prevention recommends against administering immune globulin, as it is not effective for HCV post-exposure prophylaxis, and against starting prophylactic interferon or direct-acting antivirals immediately after exposure 1, 2, 3
Testing discarded needles or syringes for virus contamination is not recommended, as results are unreliable 4, 3

If the source patient is co-infected with HIV and HCV, extended follow-up to 12 months may be warranted for the exposed healthcare worker, and standard HIV post-exposure prophylaxis protocols should be followed simultaneously if indicated based on the HIV exposure risk assessment 8